Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Current Opinion in Immunology|April 22, 2016
Defining cross presentation for a wider audienceChristopher C NorburyJournal of Virology|January 10, 2014
MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2Michael L Davies, Janet J Sei, Nicholas A Siciliano, et al.Cell Host & Microbe|June 18, 2013
Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infectionDaniel Rubio, Ren-Huan Xu, Sanda Remakus, et al.Immunologic Research|August 19, 2007
Initiation of primary anti-vaccinia virus immunity in vivoMatthew A Fischer, Christopher C NorburyImmunity|May 23, 2006
Upstream toward the "DRiP"-ing source of the MHC class I pathwayChristopher C Norbury, Eric F TewaltPlos Pathogens|January 14, 2012
Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liverRen-Huan Xu, Daniel Rubio, Felicia Roscoe, et al.Expert Opinion on Biological Therapy|June 4, 2004
Viral vectors for inducing CD8+ T cell responsesMary E Truckenmiller, Christopher C NorburyJournal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Direct CD28 costimulation is required for CD8+ T cell-mediated resistance to an acute viral disease in a natural hostMin Fang, Luis J SigalPageof 11